Tresiba and lantus?

Both Tresiba and Lantus are long-acting (basal) insulins used to provide a steady background insulin for type 1 or type 2 diabetes. The key differences are:

- Active ingredient
- Tresiba: insulin degludec
- Lantus: insulin glargine

- Duration and timing
- Tresiba: lasts about 42 hours or more; designed for flexible dosing with no strict daily time requirement.
- Lantus: lasts about 24 hours; usually taken at the same time each day.

- Dosing flexibility
- Tresiba: can be taken at varying times of day with at least 8 hours between doses.
- Lantus: best taken around the same time every day.

- Onset and peak
- Tresiba: onset in ~30–90 minutes; very flat/steady action without a pronounced peak.
- Lantus: onset in a few hours; also relatively flat, but not as prolonged as degludec.

- Concentration options
- Tresiba: available in U-100 and U-200 (the 200 U/mL form is for higher-dose needs).
- Lantus: U-100 only.

- Mixing and administration
- Neither should be mixed with other insulins in the same syringe.

- Storage and use
- Lantus: after first use, many pens/vials are kept at room temperature and discarded after about 28 days (storage rules can vary by product form; follow the label).
- Tresiba: after first use, kept at room temperature for a longer period (often up to about 8 weeks; check the label). Unopened vials/pens have separate refrigeration guidelines.

- Hypoglycemia and other effects
- Both can cause hypoglycemia and weight gain.
- Some studies suggest Tresiba may have a lower risk of nocturnal (night-time) hypoglycemia for certain patients, due to its very flat profile, but individual experience varies.

- Cost and accessibility
- Tresiba is often more expensive or may have different insurance coverage than Lantus. Check with your pharmacy or insurer.

If you’re thinking about switching between them:
- Dose adjustments may be needed; a healthcare provider usually guides the switch.
- Do not make big changes on your own; monitor fasting glucose and report it to your prescriber.

Would you like a focused comparison on a specific aspect (dosing schedule, switching guidelines, or side effects), or tell me about your current regimen and what matters most to you (flexibility, cost, hypoglycemia risk)?